Immune checkpoint inhibitors (ICI) in advanced upper tract and lower tract urothelial carcinoma (UC): A comparison of outcomes.

Stepan M. Esagian,Ali Raza Khaki,Lucía Carril-Ajuria,Joseph J. Park,Mehmet Asim Bilen,Tyler Francis Stewart,Victor Sacristan Santos,Jayanshu Jain,Rafael Morales-Barrera,Michael Edward Devitt,Christopher J. Hoimes,Evan Shreck,Abhishek Tripathi,Roubini Zakopoulou,Alejo Rodriguez-Vida,Alexandra Drakaki,Vivek Kumar,Pavlos Msaouel,Vadim S. Koshkin,Petros Grivas

Immune checkpoint inhibitors (ICI) in advanced upper tract and lower tract urothelial carcinoma (UC): A comparison of outcomes.

2021

406Background: Despite anatomical and biological differences, upper and lower tract UC (UTUC; LTUC) are usually managed similarly. Modern era clinical trial data comparing their outcomes with ICI a...

Keywords:

Oncology
upper tract
Clinical trial
immune checkpoint inhibitors
urothelial carcinoma
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations